Chronic News and Research

RSS

Update on Cardium Therapeutics' plans for commercial development of Generx

Cardium Therapeutics reported today that its Cardium Biologics division provided an update on plans for the continuing commercial development of Generx™ (alferminogene tadenovec, Ad5FGF-4), a DNA-based angiogenic therapy product candidate for patients with coronary artery disease.

27 Jan 2010

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

Patients with gastrointestinal stromal tumours (GIST) can now take action at an earlier stage of this rare form of cancer to reduce the risk of their disease returning following surgery. Novartis Pharmaceuticals Canada announced today that Gleevec* (imatinib mesylate) has received conditional approval by Health Canada for the adjuvant (post-surgical) treatment of adult patients who are at intermediate to high risk of disease recurrence following the surgical removal of GIST.

27 Jan 2010

FDA approves the NDA of Roxane Laboratories' Morphine Sulfate Oral Solution CII

Roxane Laboratories, Inc. announced today the New Drug Application (NDA) approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL) 30mL and 120mL bottles as of January 25th, 2010 by the Food and Drug Administration.

27 Jan 2010

Intercept Pharmaceuticals completes $25M Preferred Series B financing

Intercept Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for chronic fibrotic and metabolic diseases, today announced the completion of a $25 million Preferred Series B financing by its majority shareholder Genextra S.p.A.

27 Jan 2010

Innovative Alaska Health Plan outperforms many others in lower 48

Kaiser Health News reports on Alaska's Southcentral Foundation.

27 Jan 2010

FDA approves oral pain relief solution for opioid-tolerant patients

The U.S. Food and Drug Administration today approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients. This medicine will be available in 100 milligrams per 5 mL or 20 milligrams per 1 mL.

27 Jan 2010

Patients with COPD could benefit from treatment with drugs that block sestrin function

Chronic obstructive pulmonary disease (COPD) is defined by emphysema and/or chronic bronchitis. It destroys the normal architecture of the lung and inhibits the mechanical aspects of breathing, which prevents necessary gas exchange. Patients suffer from coughing fits, wheezing, and increased incidence of lung infections.

27 Jan 2010

Dynavax Technologies to present data on its SD-101 Phase 1b trial for chronic HCV infection

Dynavax Technologies Corporation announced today data from two studies that differentiate SD-101 from standard-of-care as well as emerging treatments for chronic HCV infection. The findings of a Phase 1b clinical trial and an in vitro study of SD-101's mechanism of action show that the second-generation TLR9 agonist is well tolerated and safe and induces both IFN-lambda and IFN-alpha at concentrations producing antiviral activity. The data will be presented at the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria in April 2010.

27 Jan 2010

BioScrip signs definitive agreement to acquire Critical Homecare Solutions

BioScrip, Inc. today announced it has signed a definitive agreement to acquire Critical Homecare Solutions (“CHS”), a leading provider of home infusion and home health agency services to patients suffering from chronic and acute medical conditions.

25 Jan 2010

Institute of Medicine urges healthcare providers to take steps to battle hepatitis B and C

The Institute of Medicine, a branch of the US National Academy of Sciences, is urging healthcare providers to take steps to battle liver-damaging hepatitis B and C, which are often overlooked viruses.

25 Jan 2010

Research paves way for future vaccine against gastric adenocarcinoma

Despite a strong response from our immune defence, the body is unable to rid itself of the bacterium Helicobacter pylori. One reason for this is that this bacterium encourages elements of the immune response to remain in tissue, activating the wrong immune cells. Research results that pave the way for a future vaccine are now being published by the Sahlgrenska Academy at the University of Gothenburg, Sweden.

25 Jan 2010

Interventional cardiologist accesses coronary arteries through radial artery on the inside of wrist

In an innovative new procedure, interventional cardiologist Ramesh Mazhari, MD, is one of only a few in the Washington, DC, region to access the coronary arteries through the radial artery on the inside of the wrist.

23 Jan 2010

Post-Katrina stress contributes to three-fold increase in heart attacks

Chronic stress following Hurricane Katrina contributed to a three-fold increase in heart attacks in New Orleans more than two years after levee breaches flooded most of the city, according to researchers at Tulane University School of Medicine.

23 Jan 2010

Insurance policy that allows acceleration of benefits to pay for critical health care needs

What if life insurance was designed to help policy owners live their lives, not just ease the financial burden at life's end? Quality of Life... Insurance(SM) from American General Life and Accident Insurance Company (AGLA) has taken this bold approach, which is paying off despite a volatile economy and a polarizing healthcare debate.

23 Jan 2010

New report describes state of lupus research, impact of disease and barriers to care

A major report on lupus from the Secretary of Health and Human Services to the U.S. Congress this week reviews the state of the disease and documents the need for a comprehensive national provider health education program to help eliminate the barriers of racial disparities in the early medical diagnosis and treatment of lupus.

23 Jan 2010

NJHA honors professionals and organizations for sustainable healthcare

Several individuals and organizations were honored at the 91st Annual Meeting of the New Jersey Hospital Association today at the Hyatt Regency Princeton.

23 Jan 2010

Ampyra receives FDA approval for improving walking in MS patients

The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use.

23 Jan 2010

Researchers produce DVD to help patients live with and manage neuropathic pain

Health professionals and patients can now go online for help and tips from a groundbreaking pain clinic, which halved referrals to hospital.

22 Jan 2010

Benefits of DNA testing

Does the term “genetic testing” conjure up thoughts of cloned, robot-like human beings and malevolent plots to rule the world? If so, you’ve been reading too much science fiction! The truth is, DNA testing has been put to very beneficial use for decades, primarily in the medical, law enforcement, and legal fields.

22 Jan 2010

St. Luke’s Hospital & Health Network takes major steps to reduce its carbon footprint

St. Luke’s Hospital & Health Network has taken a major step towards reducing its carbon footprint. By purchasing 10 percent of its electricity from renewable energy sources, the health system will realize an annual 2,900 ton reduction of carbon dioxide, a significant component of greenhouse gas.

22 Jan 2010

Chronic News and Research

Update on Cardium Therapeutics' plans for commercial development of Generx

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

FDA approves the NDA of Roxane Laboratories' Morphine Sulfate Oral Solution CII

Intercept Pharmaceuticals completes $25M Preferred Series B financing

Innovative Alaska Health Plan outperforms many others in lower 48

FDA approves oral pain relief solution for opioid-tolerant patients

Patients with COPD could benefit from treatment with drugs that block sestrin function

Dynavax Technologies to present data on its SD-101 Phase 1b trial for chronic HCV infection

BioScrip signs definitive agreement to acquire Critical Homecare Solutions

Institute of Medicine urges healthcare providers to take steps to battle hepatitis B and C

Research paves way for future vaccine against gastric adenocarcinoma

Interventional cardiologist accesses coronary arteries through radial artery on the inside of wrist

Post-Katrina stress contributes to three-fold increase in heart attacks

Insurance policy that allows acceleration of benefits to pay for critical health care needs

New report describes state of lupus research, impact of disease and barriers to care

NJHA honors professionals and organizations for sustainable healthcare

Ampyra receives FDA approval for improving walking in MS patients

Researchers produce DVD to help patients live with and manage neuropathic pain

Benefits of DNA testing

St. Luke’s Hospital & Health Network takes major steps to reduce its carbon footprint

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News